SlideShare a Scribd company logo
Alcohol related liver disease: prevention and prediction
Nick Sheron
0
20
40
60
80
100
120
%
Years
Percentage change in standardised UK mortality rates (age 0-64) normalised to
100% in 1970
circulatory
ischaemic heart
cerebrovascular
neoplasms
respiratory
endocrine /
metabolic
Data from WHO-HFA database downloaded Oct 2013
0
100
200
300
400
500
600
%
Years
Percentage change in standardised UK mortality rates (age 0-64) normalised to 100% in 1970
circulatory
ischaemic heart
cerebrovascular
neoplasms
respiratory
liver
endocrine / metabolic
diabetes
Data from WHO-HFA database downloaded Oct 2013
Sheron, Gilmore BMJ 2015 in press
Liver mortality Directly attributable alcohol mortality
Williams et al Lancet 2015
0100200300400500
1980 1983 1986 1989 1992 1995 1998 2001 2004 2007 2010
%changesince1980
Trends in mortality from alcohol related liver disease in England and Wales , consumption of
spirits, wine, beer and cider, and changes in duty
Alcohol related liver deaths E&W %
White spirits consumption %
Whisky consumption %
Cider consumption %
Wine consumption %
Total lager / beer consumption alcohol %
Packaged strong lager %
Marketing theory - the four p’s
• Promotion
• Product
• Place of sale
• Price
Williams et al Lancet 2015
0100200300400500
1980 1983 1986 1989 1992 1995 1998 2001 2004 2007 2010
%changesince1980
Trends in mortality from alcohol related liver disease in England and Wales , consumption of
spirits, wine, beer and cider, and changes in duty
Alcohol related liver deaths E&W %
White spirits consumption %
Whisky consumption %
Cider consumption %
Wine consumption %
Total lager / beer consumption alcohol %
Packaged strong lager %
0
50
100
150
200
250
300
350
400
0
1
2
3
4
5
6
1992 1994 1996 1998 2000 2002 2004 2006 2008 2010
Thousandhectolitres
Units/week
Average consumption of alcopops and spirits by
10-15 year old schoolchildren in England,
overlay = total UK consumption of spirits
Children Spirits
Children Alcopops
Total UK white spirits
Total UK whisky
x 5
Sheron, Gilmore BMJ 2016 in press `
0
20,000
40,000
60,000
80,000
100,000
120,000
140,000
160,000
1941
1943
1945
1947
1949
1951
1953
1955
1957
1959
1961
1963
1965
1967
1969
1971
1973
1975
1977
1979
1981*
1983*
1985*
1987*
1989*
1991
1993*
1995
1997
1999*
2001
2003
2005
2007
2009*
2011*
On licenses Off licenses
BBPA handbook 2013
Numbers of licensed premises in the UK
Lancet 2015
Nick Sheron unpublished analysis
0
1000
2000
3000
4000
5000
6000
7000
8000
0
10
20
30
40
50
60
70
80
90
100
1980 1982 1984 1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010 2012
E&Wdeathsfromchronicliverdiseaseandcirrhosis
£duty/Lpurealcohol
Changes in £ duty / L of alcohol adjusted for income and inflation
£ spirits / L alc £ beer / L alc
£ wine / L alc £ cider / L alc
E&W chronic liver disease and cirrhosis
0
5
10
15
20
25
30
35
40
45
50
0 10 20 30 40 50 60 70 80 90 100 200 300 400
%
Weekly alcohol consumption
Sheron unpublished analysis, Scottish Health Survey and Soton data
50p
Sheron et al, Clinical Medicine, 2014
MUP Policy modelling
150 units / week = 20 litres of Frosty Jack
MUP Policy modelling
15.5p / unit £23.25
70p / unit £105
Increase = £81.75 / week
The Pareto Principle or 80:20 rule
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
% of 18+ population % of alcohol units consumed
Extreme - over 75 units
Higher risk - 35/50 to 75
Increasing risk 14 to 35/50
Lower risk <=14 units
non-drinkers
0
50
100
150
200
250
300
350
400
450
%changesince1980
Spirits Afford Index Beer Afford Index Wine Afford Index
Cider Afford Index Alcohol related deaths E & W
2% tax
escalator
Nick Sheron, unpublished analysis
Survival of admissions to the Liver Unit Southampton
1/3
1/3
1/3
76%
P<0.001
Prior liver outpatient referrals in 5,112 Southampton first admissions with cirrhosis
Nick Sheron unpublished analysis
¾ of people who will
die of cirrhosis
currently have no idea
they have a liver
problem
The Southampton Liver Traffic Light Test
4,343 subjects followed for up to 12 years
SLTL n = 4,343
Mortality ROC = 0.83
Fibroscan n = 2,052
Complications C stat = 0.8
Mortality C stat = 0.67
ELF n = 457
Complications ROC = 0.87
30% reduced drinking to safe levels
65% harmful / dependent drinkers
reduced to safe levels
Traffic light test in 400 heavy drinkers in primary care, follow up after one year
Check viral serology in all
patients
Simple liver
disease
Complex liver disease Acute complex liver disease
Risk factors Alcohol, obesity, virus. Immune, metabolic Viruses, immune, drugs
Red Reduce risk factors, refer or
check for varices
Refer hepatology Traffic light may not be much
use for acute disease, check
for viral hepatitis and drugs.
Refer ALL seronegative
hepatitis urgently
Amber Reduce risk factors, repeat
traffic light 3-5 years
Liver ultrasound, refer if U/S
normal
Green Reduce risk factors Review carefully, liver
ultrasound, repeat traffic
light early
Data prodrome
Data prodrome
Nurse intervention
Control
10 GPM practices randomised to intervention / control
= audit of GP Read Codes
England
35.6m drinkers
10.4m risky drinkers
1.9m harmful drinkers
1.06m alcohol admissions
53,000 ALD admissions
6,592 alcohol related deaths
4,190 ALD deaths
Effectiveness Cost
Clinical Hepatology
LOCATE / ALLDeS teams
Miranda Kim
Magdy El-Gohari
Hazel Inskip
Colin Newell
Fangzhong Su
Emily Stimpson
Jo Dash
Tina Reinson
Jackie Hollis
Lucy Gruner
Maria Baggot
Natalie Stanton
Wendy O’Brien
Andrea Jarman
Mike Moore
Paul Roderick
Julia Sinclair
Maheswaran Naranjan
Topher Woelk
Richard Aspinall
Alan Knobel
Anonymised Hampshire Health Record Data:
HHRIGG
NHS SCW CSU

More Related Content

Viewers also liked

Uitlaat 2
Uitlaat 2Uitlaat 2
Uitlaat 2
Emre Beyy
 
Act3 equipo31e
Act3 equipo31eAct3 equipo31e
Act3 equipo31e
bredka
 
Jibril muhammad bashir2
Jibril muhammad bashir2Jibril muhammad bashir2
Jibril muhammad bashir2
Jibril Bashir
 
Mf0012 taxation management
Mf0012 taxation managementMf0012 taxation management
Mf0012 taxation management
consult4solutions
 
こがねむし会計ソフト出力マニュアル
こがねむし会計ソフト出力マニュアルこがねむし会計ソフト出力マニュアル
こがねむし会計ソフト出力マニュアル
Manabu Kondo
 
Maguey o agave
Maguey o agaveMaguey o agave
Maguey o agave
Ismail Lamarti Walter
 
Diapositivas
DiapositivasDiapositivas
Diapositivas
LETYGORDITA
 
Reading comprehensión power tools
Reading comprehensión power toolsReading comprehensión power tools
Reading comprehensión power tools
stevencas21
 
Seminario de realidad nacional en educación sussan
Seminario de realidad nacional en educación sussanSeminario de realidad nacional en educación sussan
Seminario de realidad nacional en educación sussan
StArtlet OZ
 
Presentacion power point
Presentacion power pointPresentacion power point
Presentacion power point
edwinjhonvera
 
Fire alarm 3-f-single_and_multiple-station_alarms_and_household_fire_alarm_sy...
Fire alarm 3-f-single_and_multiple-station_alarms_and_household_fire_alarm_sy...Fire alarm 3-f-single_and_multiple-station_alarms_and_household_fire_alarm_sy...
Fire alarm 3-f-single_and_multiple-station_alarms_and_household_fire_alarm_sy...
grantlerc
 
Always examine the tool for damages before use
Always examine the tool for damages before useAlways examine the tool for damages before use
Always examine the tool for damages before use
stevencas21
 

Viewers also liked (13)

basic
basicbasic
basic
 
Uitlaat 2
Uitlaat 2Uitlaat 2
Uitlaat 2
 
Act3 equipo31e
Act3 equipo31eAct3 equipo31e
Act3 equipo31e
 
Jibril muhammad bashir2
Jibril muhammad bashir2Jibril muhammad bashir2
Jibril muhammad bashir2
 
Mf0012 taxation management
Mf0012 taxation managementMf0012 taxation management
Mf0012 taxation management
 
こがねむし会計ソフト出力マニュアル
こがねむし会計ソフト出力マニュアルこがねむし会計ソフト出力マニュアル
こがねむし会計ソフト出力マニュアル
 
Maguey o agave
Maguey o agaveMaguey o agave
Maguey o agave
 
Diapositivas
DiapositivasDiapositivas
Diapositivas
 
Reading comprehensión power tools
Reading comprehensión power toolsReading comprehensión power tools
Reading comprehensión power tools
 
Seminario de realidad nacional en educación sussan
Seminario de realidad nacional en educación sussanSeminario de realidad nacional en educación sussan
Seminario de realidad nacional en educación sussan
 
Presentacion power point
Presentacion power pointPresentacion power point
Presentacion power point
 
Fire alarm 3-f-single_and_multiple-station_alarms_and_household_fire_alarm_sy...
Fire alarm 3-f-single_and_multiple-station_alarms_and_household_fire_alarm_sy...Fire alarm 3-f-single_and_multiple-station_alarms_and_household_fire_alarm_sy...
Fire alarm 3-f-single_and_multiple-station_alarms_and_household_fire_alarm_sy...
 
Always examine the tool for damages before use
Always examine the tool for damages before useAlways examine the tool for damages before use
Always examine the tool for damages before use
 

Similar to Alcohol related liver disease: prevention and prediction by Professor Nick Sheron

Changing the paradigm for liver disease - Nick Sheron
Changing the paradigm for liver disease - Nick SheronChanging the paradigm for liver disease - Nick Sheron
Changing the paradigm for liver disease - Nick Sheron
Health Innovation Wessex
 
Interesting things about alcohol in 2015/16 for alcohol awareness week
Interesting things about alcohol in 2015/16 for alcohol awareness weekInteresting things about alcohol in 2015/16 for alcohol awareness week
Interesting things about alcohol in 2015/16 for alcohol awareness week
Andrew Brown
 
Lancet liver disease infographic
Lancet liver disease infographicLancet liver disease infographic
Lancet liver disease infographic
Aimée Stewart
 
Interesting things about alcohol and other drugs - Feb 2016
Interesting things about alcohol and other drugs - Feb 2016Interesting things about alcohol and other drugs - Feb 2016
Interesting things about alcohol and other drugs - Feb 2016
Andrew Brown
 
Interesting things about alcohol and other drugs - April 2017
Interesting things about alcohol and other drugs - April 2017Interesting things about alcohol and other drugs - April 2017
Interesting things about alcohol and other drugs - April 2017
Andrew Brown
 
Most interesting things about alcohol and other drugs in 2017
Most interesting things about alcohol and other drugs in 2017Most interesting things about alcohol and other drugs in 2017
Most interesting things about alcohol and other drugs in 2017
Andrew Brown
 
Integrated Treatment for ARLD: making it happen, 2nd February 2017, Presenta...
Integrated Treatment for ARLD:  making it happen, 2nd February 2017, Presenta...Integrated Treatment for ARLD:  making it happen, 2nd February 2017, Presenta...
Integrated Treatment for ARLD: making it happen, 2nd February 2017, Presenta...
Health Innovation Wessex
 
Interesting things about alcohol and other drugs - August 2016
Interesting things about alcohol and other drugs - August 2016Interesting things about alcohol and other drugs - August 2016
Interesting things about alcohol and other drugs - August 2016
Andrew Brown
 
Alcoholic liver disease
Alcoholic liver diseaseAlcoholic liver disease
Alcoholic liver disease
Nazim Arain
 
Alcoholic liver c
Alcoholic liver cAlcoholic liver c
Alcoholic liver c
Makbul Hussain Chowdhury
 
Sir_Ian_Gilmore_-_Jan_2012_website.ppt
Sir_Ian_Gilmore_-_Jan_2012_website.pptSir_Ian_Gilmore_-_Jan_2012_website.ppt
Sir_Ian_Gilmore_-_Jan_2012_website.ppt
RozaTleubayeva
 
Combating the harms of excessive drinking in the UK
Combating the harms of excessive drinking in the UK Combating the harms of excessive drinking in the UK
Combating the harms of excessive drinking in the UK
Paul Cripps
 
Alcoholic Liver Disease (3).pptx
Alcoholic Liver Disease (3).pptxAlcoholic Liver Disease (3).pptx
Alcoholic Liver Disease (3).pptx
klrklr
 
Peter Anderson - Alcohol and Cancer
Peter Anderson - Alcohol and CancerPeter Anderson - Alcohol and Cancer
Peter Anderson - Alcohol and Cancer
Irish Cancer Society
 
LIquidity and Validity - Jan Gill
LIquidity and Validity - Jan GillLIquidity and Validity - Jan Gill
LIquidity and Validity - Jan Gill
Napier University
 
Interesting things about alcohol and other drugs - June 2016
Interesting things about alcohol and other drugs - June 2016Interesting things about alcohol and other drugs - June 2016
Interesting things about alcohol and other drugs - June 2016
Andrew Brown
 
Are Electronic Cigarettes good for Tobacco Control in Ireland? - Luke Clancy
Are Electronic Cigarettes good for Tobacco Control in Ireland? - Luke ClancyAre Electronic Cigarettes good for Tobacco Control in Ireland? - Luke Clancy
Are Electronic Cigarettes good for Tobacco Control in Ireland? - Luke Clancy
Institute of Public Health in Ireland
 
Alcoholic liver disease by Sunil Kumar Daha
Alcoholic liver disease by Sunil Kumar DahaAlcoholic liver disease by Sunil Kumar Daha
Alcoholic liver disease by Sunil Kumar Daha
sunil kumar daha
 
Local tobacco control profiles March 2019
Local tobacco control profiles March 2019Local tobacco control profiles March 2019
Local tobacco control profiles March 2019
Public Health England
 
Managing Long Term Conditions
Managing Long Term ConditionsManaging Long Term Conditions
Managing Long Term Conditions
The Health and Social Care Information Centre
 

Similar to Alcohol related liver disease: prevention and prediction by Professor Nick Sheron (20)

Changing the paradigm for liver disease - Nick Sheron
Changing the paradigm for liver disease - Nick SheronChanging the paradigm for liver disease - Nick Sheron
Changing the paradigm for liver disease - Nick Sheron
 
Interesting things about alcohol in 2015/16 for alcohol awareness week
Interesting things about alcohol in 2015/16 for alcohol awareness weekInteresting things about alcohol in 2015/16 for alcohol awareness week
Interesting things about alcohol in 2015/16 for alcohol awareness week
 
Lancet liver disease infographic
Lancet liver disease infographicLancet liver disease infographic
Lancet liver disease infographic
 
Interesting things about alcohol and other drugs - Feb 2016
Interesting things about alcohol and other drugs - Feb 2016Interesting things about alcohol and other drugs - Feb 2016
Interesting things about alcohol and other drugs - Feb 2016
 
Interesting things about alcohol and other drugs - April 2017
Interesting things about alcohol and other drugs - April 2017Interesting things about alcohol and other drugs - April 2017
Interesting things about alcohol and other drugs - April 2017
 
Most interesting things about alcohol and other drugs in 2017
Most interesting things about alcohol and other drugs in 2017Most interesting things about alcohol and other drugs in 2017
Most interesting things about alcohol and other drugs in 2017
 
Integrated Treatment for ARLD: making it happen, 2nd February 2017, Presenta...
Integrated Treatment for ARLD:  making it happen, 2nd February 2017, Presenta...Integrated Treatment for ARLD:  making it happen, 2nd February 2017, Presenta...
Integrated Treatment for ARLD: making it happen, 2nd February 2017, Presenta...
 
Interesting things about alcohol and other drugs - August 2016
Interesting things about alcohol and other drugs - August 2016Interesting things about alcohol and other drugs - August 2016
Interesting things about alcohol and other drugs - August 2016
 
Alcoholic liver disease
Alcoholic liver diseaseAlcoholic liver disease
Alcoholic liver disease
 
Alcoholic liver c
Alcoholic liver cAlcoholic liver c
Alcoholic liver c
 
Sir_Ian_Gilmore_-_Jan_2012_website.ppt
Sir_Ian_Gilmore_-_Jan_2012_website.pptSir_Ian_Gilmore_-_Jan_2012_website.ppt
Sir_Ian_Gilmore_-_Jan_2012_website.ppt
 
Combating the harms of excessive drinking in the UK
Combating the harms of excessive drinking in the UK Combating the harms of excessive drinking in the UK
Combating the harms of excessive drinking in the UK
 
Alcoholic Liver Disease (3).pptx
Alcoholic Liver Disease (3).pptxAlcoholic Liver Disease (3).pptx
Alcoholic Liver Disease (3).pptx
 
Peter Anderson - Alcohol and Cancer
Peter Anderson - Alcohol and CancerPeter Anderson - Alcohol and Cancer
Peter Anderson - Alcohol and Cancer
 
LIquidity and Validity - Jan Gill
LIquidity and Validity - Jan GillLIquidity and Validity - Jan Gill
LIquidity and Validity - Jan Gill
 
Interesting things about alcohol and other drugs - June 2016
Interesting things about alcohol and other drugs - June 2016Interesting things about alcohol and other drugs - June 2016
Interesting things about alcohol and other drugs - June 2016
 
Are Electronic Cigarettes good for Tobacco Control in Ireland? - Luke Clancy
Are Electronic Cigarettes good for Tobacco Control in Ireland? - Luke ClancyAre Electronic Cigarettes good for Tobacco Control in Ireland? - Luke Clancy
Are Electronic Cigarettes good for Tobacco Control in Ireland? - Luke Clancy
 
Alcoholic liver disease by Sunil Kumar Daha
Alcoholic liver disease by Sunil Kumar DahaAlcoholic liver disease by Sunil Kumar Daha
Alcoholic liver disease by Sunil Kumar Daha
 
Local tobacco control profiles March 2019
Local tobacco control profiles March 2019Local tobacco control profiles March 2019
Local tobacco control profiles March 2019
 
Managing Long Term Conditions
Managing Long Term ConditionsManaging Long Term Conditions
Managing Long Term Conditions
 

More from Health Innovation Wessex

Reducing opioid prescribing (in general practice)
Reducing opioid prescribing (in general practice)Reducing opioid prescribing (in general practice)
Reducing opioid prescribing (in general practice)
Health Innovation Wessex
 
Pharmacist Interventions and Medication Reviews at Care Homes - Improving Med...
Pharmacist Interventions and Medication Reviews at Care Homes - Improving Med...Pharmacist Interventions and Medication Reviews at Care Homes - Improving Med...
Pharmacist Interventions and Medication Reviews at Care Homes - Improving Med...
Health Innovation Wessex
 
The SBAR Patient Engagement Pathway Tool
The SBAR Patient Engagement Pathway ToolThe SBAR Patient Engagement Pathway Tool
The SBAR Patient Engagement Pathway Tool
Health Innovation Wessex
 
Reducing medication related falls risk in patients with severe frailty
Reducing medication related falls risk in patients with severe frailtyReducing medication related falls risk in patients with severe frailty
Reducing medication related falls risk in patients with severe frailty
Health Innovation Wessex
 
Assessing the outcomes of structured medication reviews
Assessing the outcomes of structured medication reviewsAssessing the outcomes of structured medication reviews
Assessing the outcomes of structured medication reviews
Health Innovation Wessex
 
Polypharmacy SMR reviews in outpatient bone health clinics
Polypharmacy SMR reviews in outpatient bone health clinicsPolypharmacy SMR reviews in outpatient bone health clinics
Polypharmacy SMR reviews in outpatient bone health clinics
Health Innovation Wessex
 
Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medic...
Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medic...Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medic...
Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medic...
Health Innovation Wessex
 
Evaluating the impact of a specialist frailty multidisciplinary team pathway ...
Evaluating the impact of a specialist frailty multidisciplinary team pathway ...Evaluating the impact of a specialist frailty multidisciplinary team pathway ...
Evaluating the impact of a specialist frailty multidisciplinary team pathway ...
Health Innovation Wessex
 
Genomics strategy and implementation in the NHS in England
Genomics strategy and implementation in the NHS in EnglandGenomics strategy and implementation in the NHS in England
Genomics strategy and implementation in the NHS in England
Health Innovation Wessex
 
Pharmacogenomics into practice - stroke services and a systems approach
Pharmacogenomics into practice - stroke services and a systems approachPharmacogenomics into practice - stroke services and a systems approach
Pharmacogenomics into practice - stroke services and a systems approach
Health Innovation Wessex
 
Pharmacogenomics in Practice - Dr Hayley Wickens
Pharmacogenomics in Practice - Dr Hayley WickensPharmacogenomics in Practice - Dr Hayley Wickens
Pharmacogenomics in Practice - Dr Hayley Wickens
Health Innovation Wessex
 
Working with patients to support transformational healthcare
Working with patients to support transformational healthcareWorking with patients to support transformational healthcare
Working with patients to support transformational healthcare
Health Innovation Wessex
 
The Generation study by Alice Tuff-Lacey
The Generation study by Alice Tuff-LaceyThe Generation study by Alice Tuff-Lacey
The Generation study by Alice Tuff-Lacey
Health Innovation Wessex
 
To evaluate the benefits of Structured Medication Reviews in elderly Chinese ...
To evaluate the benefits of Structured Medication Reviews in elderly Chinese ...To evaluate the benefits of Structured Medication Reviews in elderly Chinese ...
To evaluate the benefits of Structured Medication Reviews in elderly Chinese ...
Health Innovation Wessex
 
Review of patients on high dose opioids at Living Well PCN.pdf
Review of patients on high dose opioids at Living Well PCN.pdfReview of patients on high dose opioids at Living Well PCN.pdf
Review of patients on high dose opioids at Living Well PCN.pdf
Health Innovation Wessex
 
Re-establishing autonomy in elderly frail patients.pdf
Re-establishing autonomy in elderly frail patients.pdfRe-establishing autonomy in elderly frail patients.pdf
Re-establishing autonomy in elderly frail patients.pdf
Health Innovation Wessex
 
Improving Medication Reviews using the NO TEARS Tool.pdf
Improving Medication Reviews using the NO TEARS Tool.pdfImproving Medication Reviews using the NO TEARS Tool.pdf
Improving Medication Reviews using the NO TEARS Tool.pdf
Health Innovation Wessex
 
Improving care in County Durham under the STOMP agenda - A 5 year review.pdf
Improving care in County Durham under the STOMP agenda - A 5 year review.pdfImproving care in County Durham under the STOMP agenda - A 5 year review.pdf
Improving care in County Durham under the STOMP agenda - A 5 year review.pdf
Health Innovation Wessex
 
Impact of an EMIS search to prioritise care home residents for a pharmacist l...
Impact of an EMIS search to prioritise care home residents for a pharmacist l...Impact of an EMIS search to prioritise care home residents for a pharmacist l...
Impact of an EMIS search to prioritise care home residents for a pharmacist l...
Health Innovation Wessex
 
Identifying Orthostatic Hypotension caused by Medication.pdf
Identifying Orthostatic Hypotension caused by Medication.pdfIdentifying Orthostatic Hypotension caused by Medication.pdf
Identifying Orthostatic Hypotension caused by Medication.pdf
Health Innovation Wessex
 

More from Health Innovation Wessex (20)

Reducing opioid prescribing (in general practice)
Reducing opioid prescribing (in general practice)Reducing opioid prescribing (in general practice)
Reducing opioid prescribing (in general practice)
 
Pharmacist Interventions and Medication Reviews at Care Homes - Improving Med...
Pharmacist Interventions and Medication Reviews at Care Homes - Improving Med...Pharmacist Interventions and Medication Reviews at Care Homes - Improving Med...
Pharmacist Interventions and Medication Reviews at Care Homes - Improving Med...
 
The SBAR Patient Engagement Pathway Tool
The SBAR Patient Engagement Pathway ToolThe SBAR Patient Engagement Pathway Tool
The SBAR Patient Engagement Pathway Tool
 
Reducing medication related falls risk in patients with severe frailty
Reducing medication related falls risk in patients with severe frailtyReducing medication related falls risk in patients with severe frailty
Reducing medication related falls risk in patients with severe frailty
 
Assessing the outcomes of structured medication reviews
Assessing the outcomes of structured medication reviewsAssessing the outcomes of structured medication reviews
Assessing the outcomes of structured medication reviews
 
Polypharmacy SMR reviews in outpatient bone health clinics
Polypharmacy SMR reviews in outpatient bone health clinicsPolypharmacy SMR reviews in outpatient bone health clinics
Polypharmacy SMR reviews in outpatient bone health clinics
 
Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medic...
Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medic...Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medic...
Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medic...
 
Evaluating the impact of a specialist frailty multidisciplinary team pathway ...
Evaluating the impact of a specialist frailty multidisciplinary team pathway ...Evaluating the impact of a specialist frailty multidisciplinary team pathway ...
Evaluating the impact of a specialist frailty multidisciplinary team pathway ...
 
Genomics strategy and implementation in the NHS in England
Genomics strategy and implementation in the NHS in EnglandGenomics strategy and implementation in the NHS in England
Genomics strategy and implementation in the NHS in England
 
Pharmacogenomics into practice - stroke services and a systems approach
Pharmacogenomics into practice - stroke services and a systems approachPharmacogenomics into practice - stroke services and a systems approach
Pharmacogenomics into practice - stroke services and a systems approach
 
Pharmacogenomics in Practice - Dr Hayley Wickens
Pharmacogenomics in Practice - Dr Hayley WickensPharmacogenomics in Practice - Dr Hayley Wickens
Pharmacogenomics in Practice - Dr Hayley Wickens
 
Working with patients to support transformational healthcare
Working with patients to support transformational healthcareWorking with patients to support transformational healthcare
Working with patients to support transformational healthcare
 
The Generation study by Alice Tuff-Lacey
The Generation study by Alice Tuff-LaceyThe Generation study by Alice Tuff-Lacey
The Generation study by Alice Tuff-Lacey
 
To evaluate the benefits of Structured Medication Reviews in elderly Chinese ...
To evaluate the benefits of Structured Medication Reviews in elderly Chinese ...To evaluate the benefits of Structured Medication Reviews in elderly Chinese ...
To evaluate the benefits of Structured Medication Reviews in elderly Chinese ...
 
Review of patients on high dose opioids at Living Well PCN.pdf
Review of patients on high dose opioids at Living Well PCN.pdfReview of patients on high dose opioids at Living Well PCN.pdf
Review of patients on high dose opioids at Living Well PCN.pdf
 
Re-establishing autonomy in elderly frail patients.pdf
Re-establishing autonomy in elderly frail patients.pdfRe-establishing autonomy in elderly frail patients.pdf
Re-establishing autonomy in elderly frail patients.pdf
 
Improving Medication Reviews using the NO TEARS Tool.pdf
Improving Medication Reviews using the NO TEARS Tool.pdfImproving Medication Reviews using the NO TEARS Tool.pdf
Improving Medication Reviews using the NO TEARS Tool.pdf
 
Improving care in County Durham under the STOMP agenda - A 5 year review.pdf
Improving care in County Durham under the STOMP agenda - A 5 year review.pdfImproving care in County Durham under the STOMP agenda - A 5 year review.pdf
Improving care in County Durham under the STOMP agenda - A 5 year review.pdf
 
Impact of an EMIS search to prioritise care home residents for a pharmacist l...
Impact of an EMIS search to prioritise care home residents for a pharmacist l...Impact of an EMIS search to prioritise care home residents for a pharmacist l...
Impact of an EMIS search to prioritise care home residents for a pharmacist l...
 
Identifying Orthostatic Hypotension caused by Medication.pdf
Identifying Orthostatic Hypotension caused by Medication.pdfIdentifying Orthostatic Hypotension caused by Medication.pdf
Identifying Orthostatic Hypotension caused by Medication.pdf
 

Recently uploaded

Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 

Recently uploaded (20)

Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 

Alcohol related liver disease: prevention and prediction by Professor Nick Sheron

  • 1. Alcohol related liver disease: prevention and prediction Nick Sheron
  • 2. 0 20 40 60 80 100 120 % Years Percentage change in standardised UK mortality rates (age 0-64) normalised to 100% in 1970 circulatory ischaemic heart cerebrovascular neoplasms respiratory endocrine / metabolic Data from WHO-HFA database downloaded Oct 2013
  • 3. 0 100 200 300 400 500 600 % Years Percentage change in standardised UK mortality rates (age 0-64) normalised to 100% in 1970 circulatory ischaemic heart cerebrovascular neoplasms respiratory liver endocrine / metabolic diabetes Data from WHO-HFA database downloaded Oct 2013
  • 4. Sheron, Gilmore BMJ 2015 in press Liver mortality Directly attributable alcohol mortality
  • 5. Williams et al Lancet 2015 0100200300400500 1980 1983 1986 1989 1992 1995 1998 2001 2004 2007 2010 %changesince1980 Trends in mortality from alcohol related liver disease in England and Wales , consumption of spirits, wine, beer and cider, and changes in duty Alcohol related liver deaths E&W % White spirits consumption % Whisky consumption % Cider consumption % Wine consumption % Total lager / beer consumption alcohol % Packaged strong lager %
  • 6. Marketing theory - the four p’s • Promotion • Product • Place of sale • Price
  • 7. Williams et al Lancet 2015 0100200300400500 1980 1983 1986 1989 1992 1995 1998 2001 2004 2007 2010 %changesince1980 Trends in mortality from alcohol related liver disease in England and Wales , consumption of spirits, wine, beer and cider, and changes in duty Alcohol related liver deaths E&W % White spirits consumption % Whisky consumption % Cider consumption % Wine consumption % Total lager / beer consumption alcohol % Packaged strong lager %
  • 8. 0 50 100 150 200 250 300 350 400 0 1 2 3 4 5 6 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010 Thousandhectolitres Units/week Average consumption of alcopops and spirits by 10-15 year old schoolchildren in England, overlay = total UK consumption of spirits Children Spirits Children Alcopops Total UK white spirits Total UK whisky x 5 Sheron, Gilmore BMJ 2016 in press `
  • 10. Nick Sheron unpublished analysis 0 1000 2000 3000 4000 5000 6000 7000 8000 0 10 20 30 40 50 60 70 80 90 100 1980 1982 1984 1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010 2012 E&Wdeathsfromchronicliverdiseaseandcirrhosis £duty/Lpurealcohol Changes in £ duty / L of alcohol adjusted for income and inflation £ spirits / L alc £ beer / L alc £ wine / L alc £ cider / L alc E&W chronic liver disease and cirrhosis
  • 11. 0 5 10 15 20 25 30 35 40 45 50 0 10 20 30 40 50 60 70 80 90 100 200 300 400 % Weekly alcohol consumption Sheron unpublished analysis, Scottish Health Survey and Soton data
  • 12. 50p Sheron et al, Clinical Medicine, 2014
  • 13. MUP Policy modelling 150 units / week = 20 litres of Frosty Jack
  • 14. MUP Policy modelling 15.5p / unit £23.25 70p / unit £105 Increase = £81.75 / week
  • 15. The Pareto Principle or 80:20 rule 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% % of 18+ population % of alcohol units consumed Extreme - over 75 units Higher risk - 35/50 to 75 Increasing risk 14 to 35/50 Lower risk <=14 units non-drinkers
  • 16. 0 50 100 150 200 250 300 350 400 450 %changesince1980 Spirits Afford Index Beer Afford Index Wine Afford Index Cider Afford Index Alcohol related deaths E & W 2% tax escalator
  • 17. Nick Sheron, unpublished analysis Survival of admissions to the Liver Unit Southampton 1/3 1/3 1/3
  • 18. 76% P<0.001 Prior liver outpatient referrals in 5,112 Southampton first admissions with cirrhosis Nick Sheron unpublished analysis ¾ of people who will die of cirrhosis currently have no idea they have a liver problem
  • 19. The Southampton Liver Traffic Light Test 4,343 subjects followed for up to 12 years SLTL n = 4,343 Mortality ROC = 0.83 Fibroscan n = 2,052 Complications C stat = 0.8 Mortality C stat = 0.67 ELF n = 457 Complications ROC = 0.87
  • 20. 30% reduced drinking to safe levels 65% harmful / dependent drinkers reduced to safe levels Traffic light test in 400 heavy drinkers in primary care, follow up after one year
  • 21. Check viral serology in all patients Simple liver disease Complex liver disease Acute complex liver disease Risk factors Alcohol, obesity, virus. Immune, metabolic Viruses, immune, drugs Red Reduce risk factors, refer or check for varices Refer hepatology Traffic light may not be much use for acute disease, check for viral hepatitis and drugs. Refer ALL seronegative hepatitis urgently Amber Reduce risk factors, repeat traffic light 3-5 years Liver ultrasound, refer if U/S normal Green Reduce risk factors Review carefully, liver ultrasound, repeat traffic light early
  • 22. Data prodrome Data prodrome Nurse intervention Control 10 GPM practices randomised to intervention / control = audit of GP Read Codes
  • 23. England 35.6m drinkers 10.4m risky drinkers 1.9m harmful drinkers 1.06m alcohol admissions 53,000 ALD admissions 6,592 alcohol related deaths 4,190 ALD deaths Effectiveness Cost Clinical Hepatology
  • 24. LOCATE / ALLDeS teams Miranda Kim Magdy El-Gohari Hazel Inskip Colin Newell Fangzhong Su Emily Stimpson Jo Dash Tina Reinson Jackie Hollis Lucy Gruner Maria Baggot Natalie Stanton Wendy O’Brien Andrea Jarman Mike Moore Paul Roderick Julia Sinclair Maheswaran Naranjan Topher Woelk Richard Aspinall Alan Knobel Anonymised Hampshire Health Record Data: HHRIGG NHS SCW CSU